The global intraosseous infusion devices market is experiencing a remarkable surge, with demand projected to escalate from its current value of US$ 4.4 billion in 2023 to an estimated US$ 8.6 billion by 2033. This exponential growth trajectory, underscored by a robust Compound Annual Growth Rate (CAGR) of 6.9% throughout the forecast period, highlights the market’s immense potential and widespread adoption.
The latest market analysis indicates a substantial rise in demand for intraosseous infusion devices, driven by advancements in healthcare technologies and an increased focus on emergency medical care worldwide. As the need for rapid and effective vascular access in critical situations continues to escalate, this market expansion signifies a pivotal shift in medical practices and patient care.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1569
The market’s anticipated trajectory aligns with the persistent efforts of industry leaders, healthcare professionals, and innovators to enhance patient outcomes and streamline medical interventions. These devices are set to witness substantial adoption across hospitals, emergency care units, and pre-hospital settings, driven by their efficacy in delivering fluids and medications swiftly in critical situations.
The forecasted surge underscores the potential opportunities for market players to introduce innovative solutions, streamline production, and expand their global footprint. This growth trajectory not only signifies market expansion but also underscores the collective commitment to advancing healthcare by ensuring timely and effective interventions.
With a substantial Compound Annual Growth Rate (CAGR) of 6.9% projected during the forecast period, the intraosseous infusion devices market is poised to witness transformative growth, redefining the landscape of emergency medical care and underscoring its significance in optimizing patient outcomes globally.
Key Takeaways from Intraosseous Infusion Devices Market Study:
- By product, EZ-IO holds the maximum share of 20% in the market in 2021, expanding at 6.4% CAGR during the forecast period.
- By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
- By technology, the automatic segment will account for more than 50.8% of the market share in 2021.
- By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.
“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst
Click for Methodology Details: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1569
Who is winning?
Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.
- Cook Medical: Every medical profession we offer has two common threads: patients who want to be healthy and clinicians who desire more user-friendly tools. As a result, we devote significant resources to designing, manufacturing, and delivering a differentiated range of minimally invasive medical devices to healthcare systems worldwide.
- Becton Dickinson and Company: With a product line that fulfils the needs of patients, we want to increase physician satisfaction while also assisting hospitals and surgery centres in improving results and lowering expenses. BD has refined surgical instruments and led to improved results for more than a century. with a substantial portfolio and a track record of supplying high-quality items
The key market players covered by FMI include:
- Pyng Medical Corp.
- Biopsybell
- Cook Medical Incorporated
- PAVmed
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Company
- SAM Medical
- Cardinal Health, Inc
Intraosseous Infusion Devices – Market by Category:
Product:
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
By Route of Administration:
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
By Technology:
- Manual
- Automatic
- Impact Driven
- Power Drill
Inquire Before Buying This Research Report! https://www.futuremarketinsights.com/checkout/1569
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
